Pharmaceuticals, Biotechnology and Life Sciences
– $6.5mm Grant to Fund U.S. Phase I/II Leukocyte Adhesion Deficiency-I Registration-Enabling Study – NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ:…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization…
SKOKIE, Ill.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ARVO19?src=hash" target="_blank"gt;#ARVO19lt;/agt;–Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…
Total revenues of $498 million (+30% vs Q1 2018) and total product-related revenues of $458 million (+20% vs Q1 2018) for the…
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on…
If approved, cabotegravir and rilpivirine would be the first-ever long-acting, injectable treatment regimen for adults living with HIV LONDON–(BUSINESS WIRE)–ViiV…
Revenuegenerated by Hepatitis A vaccine increased by $12.0 million comparedto same period in 2017, which was offset by $13.6 million decrease in
Seed will enable growth of the PolyProx team and furtherdevelop our technology over the next two years
Allotex has treated over 50 eyes in the first phase of its clinical trials.
DUBLIN–(BUSINESS WIRE)–The “Autism – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical and…